230 related articles for article (PubMed ID: 10477295)
21. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
[TBL] [Abstract][Full Text] [Related]
22. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
23. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.
Moriishi T; Fukuyama R; Miyazaki T; Furuichi T; Ito M; Komori T
J Bone Miner Res; 2016 Jul; 31(7):1366-80. PubMed ID: 26852895
[TBL] [Abstract][Full Text] [Related]
25. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P
Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715
[TBL] [Abstract][Full Text] [Related]
26. Cthrc1 is a positive regulator of osteoblastic bone formation.
Kimura H; Kwan KM; Zhang Z; Deng JM; Darnay BG; Behringer RR; Nakamura T; de Crombrugghe B; Akiyama H
PLoS One; 2008 Sep; 3(9):e3174. PubMed ID: 18779865
[TBL] [Abstract][Full Text] [Related]
27. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
28. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.
Kacena MA; Shivdasani RA; Wilson K; Xi Y; Troiano N; Nazarian A; Gundberg CM; Bouxsein ML; Lorenzo JA; Horowitz MC
J Bone Miner Res; 2004 Apr; 19(4):652-60. PubMed ID: 15005853
[TBL] [Abstract][Full Text] [Related]
29. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
Zanotti S; Canalis E
J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
[TBL] [Abstract][Full Text] [Related]
30. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
31. Osteoblast-specific overexpression of amphiregulin leads to transient increase in femoral cancellous bone mass in mice.
Vaidya M; Lehner D; Handschuh S; Jay FF; Erben RG; Schneider MR
Bone; 2015 Dec; 81():36-46. PubMed ID: 26103093
[TBL] [Abstract][Full Text] [Related]
32. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice.
Li J; Bao Q; Chen S; Liu H; Feng J; Qin H; Li A; Liu D; Shen Y; Zhao Y; Zong Z
J Orthop Res; 2017 Apr; 35(4):812-819. PubMed ID: 27306622
[TBL] [Abstract][Full Text] [Related]
33. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
[TBL] [Abstract][Full Text] [Related]
35. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.
Costa D; Lazzarini E; Canciani B; Giuliani A; Spanò R; Marozzi K; Manescu A; Cancedda R; Tavella S
J Cell Physiol; 2013 Nov; 228(11):2210-21. PubMed ID: 23606520
[TBL] [Abstract][Full Text] [Related]
36. Accelerated Bone Loss in Transgenic Mice Expressing Constitutively Active TGF-β Receptor Type I.
Toejing P; Sakunrangsit N; Pho-On P; Phetkong C; Leelahavanichkul A; Sridurongrit S; Greenblatt MB; Lotinun S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445982
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 as possible link between loss of bone mineral density and chronic inflammation.
Ehnert S; Baur J; Schmitt A; Neumaier M; Lucke M; Dooley S; Vester H; Wildemann B; Stöckle U; Nussler AK
PLoS One; 2010 Nov; 5(11):e14073. PubMed ID: 21124921
[TBL] [Abstract][Full Text] [Related]
38. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
[TBL] [Abstract][Full Text] [Related]
39. Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.
Wan X; Li ZG; Yingling JM; Yang J; Starbuck MW; Ravoori MK; Kundra V; Vazquez E; Navone NM
Bone; 2012 Mar; 50(3):695-703. PubMed ID: 22173053
[TBL] [Abstract][Full Text] [Related]
40. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.
Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD
J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]